Clinical reviews on immunotherapy, targeted cancer therapies, screening biomarkers, chemotherapy supportive care, and clinical trials.
Evidence-based overview of early cancer detection: USPSTF screening intervals, molecular tumor markers, low-dose CT for lung cancer, and multi-cancer early detection (MCED) tests.
Medically Reviewed by Dr. Elena Rostova, MD, PhD
Clinical evaluation of oncology immunotherapy: anti-PD-1 (pembrolizumab, nivolumab) and CTLA-4 (ipilimumab) checkpoint blockades, tumor mutational burden, and immune-related adverse events.
Medically Reviewed by Dr. Elena Rostova, MD, PhD
Evidence-based clinical guidelines on chemotherapy antiemetic regimens: NK1 receptor antagonists, 5-HT3 antagonists, olanzapine, and dexamethasone for highly emetogenic chemotherapy.
Medically Reviewed by Dr. Elena Rostova, MD, PhD
Technical and clinical comparison of modern radiation oncology modalities: 3D conformal, IMRT with multileaf collimation, proton therapy, and stereotactic ablative radiotherapy (SBRT).
Medically Reviewed by Dr. Elena Rostova, MD, PhD
Clinical classification of breast cancer: Luminal A, Luminal B, HER2-enriched, and Triple-Negative subtypes, targeted therapies, and Oncotype DX recurrence scores.
Medically Reviewed by Dr. Elena Rostova, MD, PhD
Surgical and oncologic review of colorectal carcinoma: adenoma-carcinoma sequence, high-definition colonoscopy, TNM staging, total mesorectal excision, and FOLFOX adjuvant chemotherapy.
Medically Reviewed by Dr. Elena Rostova, MD, PhD
Clinical utility of circulating tumor DNA (ctDNA) liquid biopsies: detecting minimal residual disease (MRD), monitoring treatment response, and identifying acquired drug resistance mutations.
Medically Reviewed by Dr. Elena Rostova, MD, PhD
Comprehensive clinical diagnostic pathways in hematology-oncology: bone marrow biopsy, immunophenotyping, BCR-ABL1 tyrosine kinase inhibitors, and CAR-T cell immunotherapy.
Medically Reviewed by Dr. Elena Rostova, MD, PhD
Evidence-based palliative oncology: landmark Temel trial data, multi-modal cancer pain management, equianalgesic opioid conversion, and advance care planning.
Medically Reviewed by Dr. Elena Rostova, MD, PhD
